Skip to content
Abierto

Special notice

Notice of Intent to Sole Source – Stemcell Technologies

26-000433

National Institutes of Health, National Institutes of Health - CC. Surgical and Medical Instrument Manufacturing.

Awarded

Stemcell Technologies Inc.

$48,548.00 obligated so far on USAspending

Description

As published on SAM.gov.

The purpose of this acquisition is to purchase cell separator kits for the Department of Laboratory Medicine (DLM) at National Institutes of Health (NIH) Clinical Center (CC). • Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies • NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing • Place of Performance:

Bethesda, MD 20892 USA POTS:

26-000433 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order STEMCELL TECHNOLOGIES INC, located at 6425 S 216th St Bldg F, Kent, WA, on a firm fixed price sole source award basis to provide EasySep cell separator kits for the Department of Laboratory Medicine (DLM) at National Institutes of Health (NIH) Clinical Center (CC).

StemCell Technologises is the sole manufacturer of these kits used on the RoboSep instruments currently used in DLM. No other vendors can supply them to meet the clinical and research requirements of the Department of Laboratory Medicine.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.

Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by December 19, 2025 at 12pm EST.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
ELPMWCGFK518
CAGE
3JPG0
Vendor location
Kent, WA
Contract
75N90026P00045, purchase order
Obligated
$48,548.00
Actions
1 between January 8, 2026 and January 8, 2026
Competition
Not Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Stemcell Technologies INC:1109892 [26-000433]
Match
solicitation number 26000433 equals the FPDS solicitation identifier; same awarding office 75N900 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. December 16, 2025

    Special notice

    Due December 19, 2025 at 10:00 AM EST. SAM.gov, notice 22ef0794900a438a8c8e3a5aa947fb1c

Points of contact